All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-ZP1622 | Anti-MET (DO-24) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | DO-24 | Humanized | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-ZP1670 | Anti-MET (LMH87) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | LMH87 | Human | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-ZP1671 | Anti-MET (LMH87) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | LMH87 | Human | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-ZP1672 | Anti-MET (huAbF46-H4-A5) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | huAbF46-H4-A5 | Human | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-ZP1673 | Anti-MET (huAbF46-H4-A5) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | huAbF46-H4-A5 | Human | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-ZP1674 | Anti-MET (A1) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | A1 | Human | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-ZP1675 | Anti-MET (A1) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | A1 | Human | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-ZP1676 | Anti-MET (5D5) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 5D5 | Human | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-ZP1677 | Anti-MET (5D5) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | 5D5 | Human | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-ZP1678 | Anti-MET (Emibetuzumab) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | Emibetuzumab | Human | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-ZP1679 | Anti-MET (Emibetuzumab) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | Emibetuzumab | Human | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-ZP1680 | Anti-MET (H2) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | H2 | Human | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-ZP1681 | Anti-MET (H2) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | H2 | Human | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-ZP1682 | Anti-MET (LMH89) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | LMH89 | Human | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-ZP1683 | Anti-MET (LMH89) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | LMH89 | Human | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-ZP1684 | Anti-MET (9G22) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 9G22 | Human | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-ZP1685 | Anti-MET (9G22) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | 9G22 | Human | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-ZP1687 | Anti-MET (E9) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | E9 | Human | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-ZP1688 | Anti-MET (DS2216AB) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | DS2216AB | Human | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-ZP1689 | Anti-MET (DS2216AB) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | DS2216AB | Human | scFv-41BB-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION